Raysearch Laboratories
140.6 SEK +1.15%3 investors are following this company
RaySearch Laboratories is a biotechnology company. The company specializes in the development of software solutions for the healthcare industry. An area where the company's products are used is in the treatment of cancer and other serious diseases. The company's products include products for dose planning and information systems. Various features include machine learning, computational speed, automated planning, virtual simulation, adaptive therapy, and digital workflows. The products are used by several clinics around the global market.
Read moreRevenue
-
EBIT %
-
P/E
59.08
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
RAY B
Daily low / high price
138.2 / 140.8
SEK
Market cap
4.82B SEK
Turnover
1.35M SEK
Volume
9.7K
Financial calendar
Interim report
16.08.2024
Interim report
08.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Johan Löf | 16.5 % | 53.0 % |
Northern Trust Company, London Branch | 8.1 % | 2.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
RaySearch Laboratories: RaySearch releases RayStation 2024B
RaySearch Laboratories: RayStation Used for First-Ever Radiotherapy Treatment with Hitachi's OXRAY system
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools